1. Home
  2. PMCB vs GMM Comparison

PMCB vs GMM Comparison

Compare PMCB & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.60

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

HOLD

Current Price

$2.77

Market Cap

6.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
GMM
Founded
1996
2017
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
6.8M
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
PMCB
GMM
Price
$0.60
$2.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
86.0K
3.9M
Earning Date
03-17-2026
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
277.22
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.06
52 Week High
$1.51
$5.79

Technical Indicators

Market Signals
Indicator
PMCB
GMM
Relative Strength Index (RSI) 37.13 51.96
Support Level N/A $1.25
Resistance Level $0.77 $4.75
Average True Range (ATR) 0.04 0.67
MACD -0.01 -0.06
Stochastic Oscillator 24.26 24.81

Price Performance

Historical Comparison
PMCB
GMM

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital asset development for the metaverse industry. The Company leverages its proprietary Mofy Lab technology platform, which integrates three-dimensional (3D) reconstruction technology and artificial intelligence (AI) interactive technology, to create high-definition virtual versions of physical world objects, including humans, animals, and scenes. It provides comprehensive technology solutions to support virtual content production for use across movies, television series, animation, advertising, and gaming. The Company operates through Virtual Technology Services, which generates the majority of revenue, and Digital Asset Development and others.

Share on Social Networks: